Summit Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.0M | 195k | 20.66 |
| 2025-06-30 | $1.1M | 51k | 21.28 |
| 2025-03-31 | $39M | 2.0M | 19.29 |
| 2024-12-31 | $6.9M | 387k | 17.85 |
| 2024-09-30 | $9.4M | 431k | 21.90 |
| 2024-06-30 | $7.9M | 1.0M | 7.80 |
| 2023-06-30 | $26k | 10k | 2.51 |
| 2023-03-31 | $62k | 36k | 1.75 |